SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor - Hoffmann, M; Kleine-Weber, H; Schroeder, S; Krüger, N; Herrler, T; Erichsen, S; Schiergens, T; Herrler, G; Wu, N H; Nitsche, A; Müller, M; Drosten, C; Pöhlmann, S (Cell, 2020)